Tilray Brands Long Term Debt 2017-2025 | TLRY
Tilray Brands long term debt from 2017 to 2025. Long term debt can be defined as the sum of all long term debt fields.
|
Tilray Brands Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2025 | $300 |
| 2024 | $348 |
| 2023 | $366 |
| 2022 | $520 |
| 2021 | $889 |
| 2020 | $306 |
| 2020 | $295 |
| 2019 | $430 |
| 2018 | $429 |
| 2017 | $9 |
| 2017 | |
| 2016 | $9 |
| 2016 | |
|
Tilray Brands Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-08-31 | $228 |
| 2025-05-31 | $235 |
| 2025-02-28 | $314 |
| 2024-11-30 | $334 |
| 2024-08-31 | $288 |
| 2024-05-31 | $348 |
| 2024-02-29 | $365 |
| 2023-11-30 | $363 |
| 2023-08-31 | $281 |
| 2023-05-31 | $366 |
| 2023-02-28 | $321 |
| 2022-11-30 | $384 |
| 2022-08-31 | $568 |
| 2022-05-31 | $520 |
| 2022-02-28 | $622 |
| 2021-11-30 | $707 |
| 2021-08-31 | $777 |
| 2021-05-31 | $889 |
| 2021-03-31 | $259 |
| 2021-02-28 | |
| 2020-12-31 | |
| 2020-11-30 | |
| 2020-09-30 | $514 |
| 2020-08-31 | |
| 2020-06-30 | $509 |
| 2020-03-31 | $500 |
| 2019-12-31 | |
| 2019-09-30 | $437 |
| 2019-06-30 | $434 |
| 2019-03-31 | $432 |
| 2018-12-31 | $429 |
| 2018-09-30 | $9 |
| 2018-06-30 | $8 |
| 2018-03-31 | $8 |
| 2018-02-28 | |
| 2017-12-31 | $9 |
| 2017-11-30 | |
| 2017-09-30 | |
| 2017-08-31 | |
| 2017-06-30 | |
| 2017-05-31 | |
| 2017-03-31 | |
| 2017-02-28 | $9 |
| 2016-11-30 | $9 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.213B | $0.821B |
| Tilray Brands Inc. is a cannabis-lifestyle and consumer packaged goods company. It operates principally in Canada, the United States, Europe, Australia and Latin America. Tilray Brands Inc., formerly known as Tilray Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.079B | 26.17 |
| EssilorLuxottica (ESLOY) | France | $171.331B | 0.00 |
| Boston Scientific (BSX) | United States | $152.232B | 34.81 |
| Stryker (SYK) | United States | $138.522B | 27.50 |
| Medtronic (MDT) | Ireland | $122.971B | 17.34 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.219B | 0.00 |
| Agilent Technologies (A) | United States | $41.624B | 26.94 |
| ResMed (RMD) | United States | $35.677B | 24.69 |
| GE HealthCare Technologies (GEHC) | United States | $33.321B | 15.94 |
| Koninklijke Philips (PHG) | Netherlands | $27.607B | 18.03 |
| Insulet (PODD) | United States | $23.404B | 72.64 |
| Terumo (TRUMY) | Japan | $22.638B | 25.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.819B | 11.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.952B | 0.00 |
| Baxter (BAX) | United States | $9.495B | 7.66 |
| Sunny Optical Technology (SNPTF) | China | $9.361B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.447B | 30.37 |
| Demant (WILYY) | Denmark | $7.346B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.515B | 10.71 |
| Haemonetics (HAE) | United States | $3.440B | 15.31 |
| ICU Medical (ICUI) | United States | $3.370B | 21.40 |
| Envista Holdings (NVST) | United States | $3.190B | 18.30 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.886B | 13.16 |
| LeMaitre Vascular (LMAT) | United States | $2.006B | 40.38 |
| Perrigo (PRGO) | Ireland | $1.896B | 4.75 |
| Phibro Animal Health (PAHC) | United States | $1.828B | 18.26 |
| AtriCure (ATRC) | United States | $1.636B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.450B | 9.32 |
| Neogen (NEOG) | United States | $1.389B | 26.62 |
| Curaleaf Holdings (CURLF) | Canada | $1.385B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.287B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.245B | 18.02 |
| Green Thumb Industries (GTBIF) | United States | $1.195B | 52.36 |
| BioLife Solutions (BLFS) | United States | $1.159B | 343.86 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.931B | 0.00 |
| InMode (INMD) | Israel | $0.896B | 10.12 |
| Valneva SE (VALN) | France | $0.778B | 0.00 |
| Surmodics (SRDX) | United States | $0.595B | 0.00 |
| Omeros (OMER) | United States | $0.558B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.495B | 17.03 |
| CeriBell (CBLL) | United States | $0.479B | 0.00 |
| Evolus (EOLS) | United States | $0.468B | 0.00 |
| SNDL (SNDL) | Canada | $0.441B | 0.00 |
| BillionToOne (BLLN) | $0.402B | 0.00 | |
| Cresco Labs (CRLBF) | United States | $0.344B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.340B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Cerus (CERS) | United States | $0.311B | 0.00 |
| Brainsway (BWAY) | Israel | $0.308B | 52.53 |
| Sanuwave Health (SNWV) | United States | $0.283B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.257B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.256B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.244B | 143.67 |
| Viemed Healthcare (VMD) | United States | $0.243B | 19.36 |
| High Tide (HITI) | Canada | $0.236B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.227B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Exagen (XGN) | United States | $0.204B | 0.00 |
| Organigram Global (OGI) | Canada | $0.204B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 15.64 |
| FitLife Brands (FTLF) | United States | $0.170B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.166B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.149B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.126B | 0.00 |
| Biote (BTMD) | United States | $0.115B | 5.04 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.091B | 13.25 |
| Sharps Technology (STSS) | United States | $0.087B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.049B | 20.77 |
| Nephros (NEPH) | United States | $0.047B | 33.85 |
| Cytosorbents (CTSO) | United States | $0.041B | 0.00 |
| Jin Medical (ZJYL) | China | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Modular Medical (MODD) | United States | $0.029B | 0.00 |
| Bonk (BNKK) | United States | $0.029B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.30 |
| Zynex (ZYXI) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Functional Brands (MEHA) | $0.003B | 0.00 | |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |